Farallon Capital Management »

Hims & Hers Heal shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Hims & Hers Heal (HIMS) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Hims & Hers Heal

Tip: Access up to 7 years of quarterly data

All positions including Hims & Hers Heal held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hims & Hers Heal by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $264k 42k 6.29

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Activision Blizzard
Horizon Therapeutics Pub L SHS
UnitedHealth (UNH)
Transunion (TRU)
Exelixis (EXEL)
Iqvia Holdings (IQV)
Thermo Fisher Scientific (TMO)
salesforce (CRM)
Charter Communications Inc N Cl A (CHTR)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Aramark Hldgs (ARMK)
Astrazeneca Sponsored Adr (AZN)
S&p Global (SPGI)

View all positions for Farallon Capital Management

Top funds holding Hims & Hers Heal

Vanguard Group
Redpoint Management
Marshall Wace
Bank of America Corporation
Citadel Advisors
Dimensional Fund Advisors
Millennium Management
Franklin Resources
Susquehanna International
Connor, Clark & Lunn Investment Management
Cubist Systematic Strategies
Charles Schwab Investment Management
Goldman Sachs Group
Alliancebernstein
Jupiter Asset Management

View all funds holding Hims & Hers Heal